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Abstract
Objective: Proper arterial and venous specification is a hallmark of functional vascular networks. While arterial-venous
identity is genetically pre-determined during embryo development, it is unknown whether an analogous pre-specification
occurs in adult neovascularization. Our goal is to determine whether vessel arterial-venous specification in adult
neovascularization is pre-determined by the identity of the originating vessels.
Methods and Results: We assessed identity specification during neovascularization by implanting isolated microvessels of
arterial identity from both mice and rats and assessing the identity outcomes of the resulting, newly formed vasculature.
These microvessels of arterial identity spontaneously formed a stereotypical, perfused microcirculation comprised of the full
complement of microvessel types intrinsic to a mature microvasculature. Changes in microvessel identity occurred during
sprouting angiogenesis, with neovessels displaying an ambiguous arterial-venous phenotype associated with reduced
EphrinB2 phosphorylation.
Conclusions: Our findings indicate that microvessel arterial-venous identity in adult neovascularization is not necessarily
pre-determined and that adult microvessels display a considerable level of phenotypic plasticity during neovascularization.
In addition, we show that vessels of arterial identity also hold the potential to undergo sprouting angiogenesis.
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Introduction
The formation of a new, functional post-natal vascular bed by
neovascularization depends on complex vascular adaptation pro-
cesses. Typically, immature neovessels formed during sprouting
angiogenesis must undergo vascular wall maturation and assemble
into an effective perfusion circuit comprised of in-flow, exchange,
and out-flow vascular pathways. Important in this process is the
structural adaptation of the angiogenesis-derived neovessels, often
devoid of perivascular coverage, into vessels with sufficient st-
ructural integrity and functional activity to accommodate and
regulate blood flows and pressures [1,2]. Just as important as and,
perhaps, integral to this structural adaptation is the specification of
arterial and venous identity [3]. In the absence of proper arterial-
venous (AV) specification, vascular networks are improperly
formed and dysfunctional [4].
It is thought that in the embryo AV differentiation is genetically
pre-determined based on studies demonstrating that AV-specific
proteins such as EphrinB2 and its receptor EphB4 are expressed in
arterial and venous cells, respectively, in angioblasts prior to the
onset of blood flow and heart beat [5,6,7]. In the embryo, in-
duction of AV specific markers expression occurs when VEGF
signals via VEGF receptor-2/Neuropilin-1 complex in arterial-
fated angioblasts leading to the downstream activation of Notch
and ERK signaling pathways and the subsequent expression of the
arterial marker EphrinB2. Expression of Notch signaling pathway
molecules in veins is suppressed by the transcription factor COUP-
TFII, preventing Notch signaling and inducing the expression of
the venous marker EphB4 [3,8,9,10,11].
While embryonic AV specification is, in part, pre-determined,
environmental cues are also important. Studies in avian embryos have
shown that in early stages of development, endothelial cells of either
arterial or venous origin could colonize and acquire characteristics of
both arteries and veins [12]. Moreover, the expression of arterial- and
venous-specific genes changed to reflect the specific type of vessel used
as the engraftment site. Interestingly, this plasticity (i.e. ability
to change AV identity) was progressively lost at later stages of
development [12], suggesting that the more committed/differentiated
the cells are the less likely they are to change phenotype.
Compartmentalized expression of the AV markers EphrinB2 and
EphB4 in mature vessels continues into adulthood [13,14], raising the
possibility that the parent vessel from which neovessels are originated
may influence the identity of the newly forming microvessels. Whether
vessel identity during neovascularization in the adult is pre-determined,
analogous to that in the embryo, is not known. This is relevant to neo-
vascularization therapies in which a complete vascular bed containing
arterioles, capillaries and venules must be generated to form a
competent vasculature and is particularly important in regenerative
therapies where microvessel fragments of different AV identities have
been successfully used to treat myocardial infarction [15].
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27332To address whether adult microvessel AV identity is defined by the
originating vessel identity or if adult vessels hold the potential to change
identity, we used an implant system comprised of defined types of
isolated microvessel segments to evaluate the ability of microvessels of a
single identity to form a normal microcirculation following neovascu-
larization. We have previously shown that the use of all three general
types of microvessels (arterioles, capillaries, and venules) in this implant
system results in the formation of a complete, functional microvascu-
lature, derived from the isolate, after implantation. This microvascular
b e di sf o r m e dt h r o u g har e g i m e n t e dp r o c e s sw h e r em i c r o v e s s e l
fragments undergo angiogenesis, post-angiogenesis neovascular re-
modeling and network maturation [16,17]. We hypothesized that if
new vessel identity is pre-determined by the parent microvessel
identity, then the formation of a proper microvascular network should
be compromised in the implants if solely one microvessel type (e.g.
arterioles) was used. Conversely, the development of a typical,
hierarchical vascular tree from this single specified microvessel source
would indicate that pre-determination either does not occur or is over-
ridden during the post-angiogenesis adaptation.
Results
Isolation of arteriole segments with magnetic beads
yields a functional, highly enriched arterial fraction
To enrich isolates for segments of arterial identity, the rodent
brain vasculature was perfused with magnetic beads (average
11 mm OD) prior to microvessel segment isolation. Due to their
size and the delivery method (via the left common carotid artery),
the beads lodge in the arterial side of the vasculature (Fig. 1A)
allowing for arterioles to be separated from venules and capillaries
using a magnet following normal vessel isolation (Fig. 1B). Ar-
terial purity was determined by performing the isolation from mice
containing a Histone H2B-GFP transgene under control of the
indigenous Efnb2 promoter [18]. This allowed us to clearly
distinguish vessels of arterial identity (GFP-positive) from other
vessels (GFP-negative). With this modified approach, the isolation
was significantly enriched for artery-side microvessels (97.161%
arterioles versus 66.363% in the total isolate containing all micro-
vessel types) (Fig. 1C). Magnetic beads remain in the isolated
arterioles; however, they do not impair the angiogenic potential of
the isolated microvessels (Fig. 1D, E).
Segments of arterial identity give rise to a competent,
hierarchical microcirculation
To assess vessel identity specification in the adult, we cha-
racterized the vessel types formed in an implanted microvascular
construct (MVC) in which greater than 97% of the microvessels
are arterioles (Fig. 2). As a comparison to these arteriole-only
microvascular constructs (aMVC), we prepared MVCs derived
from a total isolate (tMVCs) in which all microvessel types (roughly
2/3 arterioles and 1/3 capillaries/venules) were present. After 6
weeks of implantation, both aMVCs and tMVCs contained newly
Figure 1. Isolation of arteriole segments with magnetic beads yields a functional, highly enriched arterial fraction. A and B, Isolated
brain microvessel segments preloaded with magnetic beads prior to (A) and following (B) extraction with a magnet. Scale bar=200 mm. C, Repeated
use of a magnet to pull out bead-loaded microvessels highly enriches the isolate for segments expressing the Efnb2-GFP reporter. (n=3), *p,0.05 by
Student’s t-test. Phase (D) and fluorescence (E) images of cultured, bead-loaded microvessel segments with sprouting neovessels (arrows). Scale
bar=100 mm.
doi:10.1371/journal.pone.0027332.g001
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perivascular cell coverage and microvessel morphologies consistent
with mature arteriole, capillary and venule structures (Fig. 2A–E).
Importantly, all perfused mature vessels were isolate-derived as
these microvessels were GFP-positive (isolates were prepared from
rats that ubiquitously express GFP) (Fig. 2A, B). Assessment of
the microvessel caliber within the aMVC implants demonstrated
a broad distribution of diameters consistent with a typical
hierarchical vascular tree and similar to neovasculatures formed
from total microvessel isolates (Fig. 2F). Repeating the experi-
ments using the Efnb2-reporter mouse as the source of microvessel
segments (to identify mature arterial identity) demonstrated that
,60% of the mature microvessels within the microvasculatures of
the implanted aMVCs were positive for the arterial marker
(Fig. 3A–D), implying that the remaining nearly 40% of the
mature microvessels were either venous or capillary in identity.
Figure 2. Microvessel segments of arterial identity form a competent, hierarchical microcirculation when implanted. A–D, Confocal
microscopy images (Z-projections) of microvascular networks in MVCs derived from total isolates (tMVC) or arterial-enriched isolates (aMVC) and
implanted for 6 weeks. In all cases, microvessel segments were isolated from brain tissue of GFP-expressing transgenic rats. The scale bar in
(A)=100 mm and applies to all panels. (A, B). Host mice were injected intravenously with dextran-TRITC (red) to identify implant microvessels (green)
that were perfusion-competent or (C, D) MVC implants were immunostained for alpha smooth muscle actin (red) to identify perivascular cell
morphology. Arrows indicate arterioles, arrowheads indicate venules and capillaries. (E) Analysis of perfusion-competence of microvessels in total-
(tMVC) and arterial-derived (aMVC) implanted MVCs 6 weeks post-implantation. Vessel perfusion was measured as the % fraction of green vessels
exhibiting red dye in their lumens. (F) The distribution of vessel diameters, as an index of network architecture, in 4 week total (tMVC) and arterial
(aMVC) MVC implants plotted as the frequency of diameters placed into bins of 5 mm increments. Vessel diameter distribution from tMVC is
Reprinted from [16] with permission from Elsevier.
doi:10.1371/journal.pone.0027332.g002
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microvessels isolated from the Ephb4-reporter mouse confirmed
the presence of venous-identity vessels (Fig. 3E, F). Because the
perfused vessels originated from donor vessels (and consistent with
our previous findings [16]), we can rule out the possibility that the
EphrinB2- negative, EphB4-positive vessels present in the MVCs
originated from the host vasculature. Additionally, while it’s pos-
sible that the non-arteriole contaminants in the aMVCs gave rise
to the non-arteriole vessels in the resulting mature microvascular
tree, the very small fraction of these contaminants (,3%) makes
this seem unlikely. Therefore, these findings indicate that parent
microvessels of a single identity were capable of deriving a
complete microvasculature comprised of all microvessel types.
From this, we conclude that vessel identity in new microvascular
networks generated during adult neovascularization is not pre-
determined.
Changes in vessel identity coincides with sprouting
angiogenesis
The development of venules (and capillaries) from arterial mi-
crovessels indicates that a change in vessel identity occurred during
the neovascularization process. Because sprouting neovessels in the
implants lose the morphological features of their respective parent
microvessel fragments (i.e. display uniform, narrow diameters and
lack perivascular cell coverage [16]), we hypothesized that identity
changes were initiated during sprouting angiogenesis. Therefore,
we assessed vessel identity in tMVCs in the sprouting angiogenic
phase through the use of reporter mice-isolated vessels. An
advantage of using tMVC is that it allows us to see changes in
vessel identity in all vessels types, not only in arterioles. Indeed,
nearly 100% of the angiogenic neovessels in implanted tMVCs
were positive for Efnb2-o rEphb4-reporter expression (Fig. 4A–C)
using both brain- (not shown) and adipose-derived isolates sug-
gesting that regardless of vessel type, vessel sprouts undergo vessel
identity changes during sprouting angiogenesis. Co-expression of
the reporters in single, angiogenic neovessels was corroborated by
specific immunostaining of Efnb2-reporter neovessels for EphB4
(Fig. 4D). This is consistent with a previous study in which
EphrinB2 and EphB4 were reported to be co-expressed in retinal
endothelial sprouts [19] and indicates that neovessels generated
during sprouting angiogenesis do not retain the identity distinction
of the parent microvessels and may even display a mixed AV
identity.
While the reporter activity in the transgenic mice identifies
active Efnb2 and Ephb4 promoters, it does not reflect actual levels
of these proteins in vascular cells. Given that the angiogenic
neovessels in the MVC have few morphological characteristics of
either an arteriole or venule [16] yet have active vessel-type gene
promoter activity (i.e. the reporters), we questioned whether or not
endogenous identity marker proteins are actually present in the
vascular cells. Western blots of lysates prepared from fresh isolates
of mature, specified microvessels and angiogenic neovessels from
tMVCs showed that while the reporter experiments indicate that
nearly all of the neovessels of the implanted MVC have an active
Efnb2 promoter (reporter expression and Fig. 4E), total EphrinB2
protein expression was significantly reduced (Fig. 5A). Further-
more, the phosphorylation status of EphrinB2, thought important
in activation and the positive regulation of endothelial cell and
perivascular cell interactions [20], was significantly lower in an-
giogenic neovessels than in mature, specified vessels (Fig. 5B). A
similar downward trend was also observed with EphB4 transcript,
COUP-TFII (another venous marker [21]) protein and transcript
(Figs. 5 and 4E), and Jag1 transcript (Fig. 4E). Therefore, while,
the continued activity of both arterial and venous marker gene
promoters in the sprouting neovessels suggests that the change in
Figure 3. Mature microvessels derived from arterial segments express arterial and venous markers. A–C, Representative confocal
images (Z-projections) of vessel networks in MVCs derived from arterial-isolates obtained from Efnb2-reporter mice implanted for 6 weeks expressing
the arterial reporter (Efnb2 in green) and filled with a blood tracer (perfusion in red). Scale bar=100 mm. D, The % of perfused microvessels (red)
positive for the Efnb2-reporter (green). * p,0.05 by Student’s t-test. E and F, Histology sections of 6 week-aMVC implants derived from an Ephb4-
reporter transgenic mouse. Explants were sectioned and incubated with the b-galactosidase substrate X-gal to produce a blue precipitate as a marker
of Ephb4 expression (arrows in E, scale bar=50 mm.) or no precipitate indicating an Ephb4-reporter negative vessel (arrows in F, scale bar=25 mm).
doi:10.1371/journal.pone.0027332.g003
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in a mixed AV identity, the apparent reduction in these proteins
suggests that the neovessels are losing specific vessel-type character
during angiogenesis and acquiring a more generic, ambiguous
vascular phenotype. Of course it is possible that, since these
proteins serve different functions during vessel sprouting [22] other
than establishing vessel identity, these molecules may not serve as
effective identity markers in this setting. Interestingly, transcript
levels for Dll4 and Notch4, molecules downstream of the VE-
GFR2/NRP-1 signaling complex in the arterial specification
pathway and therefore also possible markers of arterial identity
[3,11,23], were not different in the angiogenic sprouts (Fig. 4E).
However, these proteins are also important in establishing tip and
stalk cell identity in the angiogenic sprout [24] and mediate sprout
branching [25], roles that are not necessarily specific to marking
AV identity.
Figure 4. Angiogenic neovessels express arterial and venous genetic markers. A–C, Confocal images (Z-projections) of angiogenic
neovessels in tMVC implants during the sprouting angiogenic phase (week 1 post-implantation) obtained from (A) Efnb2- or (B) Ephb4-reporter mice.
Microvessels were identified by labeling endothelial cells with TRITC-conjugated GS-I lectin (red). Ephb4-driven LacZ expression shown in panel B was
detected with an anti-b-galactosidase-FITC antibody. C, Determination of the % fraction of angiogenic neovessels positive for either the Efnb2-o r
Ephb4-reporter in tMVCs prepared as in A and B. D, Co-expression of the Efnb2-reporter gene and EphB4 in individual angiogenic neovessels in 1
week tMVC implants prepared from Efnb2-reporter mice (green) and immunostained with an anti-EphB4 antibody (red). Scale bar in all
panels=100 mm. E, Real-time PCR measurement of mRNA expression of EphrinB2, EphB4, COUP-TFII, Delta-like4 (Dll4), Jag1 and Notch4 genes in
freshly isolated, specified microvessels (mature) and angiogenic neovessels in tMVCs (angiogenic). * p,0.05, n=3 by Student’s t-test.
doi:10.1371/journal.pone.0027332.g004
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We show here that vessel segments of arterial identity are
capable of giving rise to the full spectrum of vessel types intrinsic to
a functional microcirculation in neovascularization. The findings
are consistent with the concept that microvessel AV identity in
adult neovascularization is not necessarily pre-determined and that
adult microvessels display a considerable level of phenotypic ada-
ptation and plasticity. Whether capillaries or venules have similar
plastic capabilities is not clear. However, given that sprouting
occurs from capillaries and venules as well as arterioles in tMVCs
(unpublished observation), it’s likely that non-arteriole types share
this same phenotypic plasticity. The absence of pre-determination
in adult neovascularization is in contrast to the embryo in which
vessel identity, at least during the early phases of vascular for-
mation, is pre-determined by a complex molecular program [26].
This may reflect the intrinsic de novo assembly of the embryonic
vasculature, which is not prominent in adult neovascularization.
A common clinical solution to peripheral revascularization is to
use veins as artery grafts [27]. Interestingly, while these vein grafts
adapt to the new vascular position (e.g. wall thickening [27]), they
do not fully convert to an artery phenotype. For example, saph-
enous vein grafts used in patients lost the EphB4 expression (i.e.
lost their venous identity) but did not express EphrinB2 (i.e. exhibit
an arterial molecular phenotype) [28], suggesting that mature
adult vessels have limited plasticity. This in contrast to the findings
of our present study in which there was complete identity
conversion. This difference in plasticity may reflect an intrinsic
plasticity character between large vessels, such as used in vein
grafting, and microvessels (the focus of our study). However, given
that the microvessels in the implanted construct underwent
profound changes to the vessel wall structure intrinsic to
angiogenesis and neovascularization [16] while the wall structure
is essentially preserved in vein grafts, perhaps complete vessel
plasticity in the adult is contingent upon extensive vessel wall
restructuring and may only occur during neovascularization.
The co-expression of both AV markers in neovessels in MVCs is
consistent with a report that shows co-expression of EphrinB2 and
EphB4 in tip and stalk cells in retinal sprouts [19] and suggests that
changes in identity appear to result in a mixed AV identity.
However, the reduced EphrinB2 expression and activation and the
absence of morphologies characteristic of specific microvessel
identities [16] in the implant system raises the possibility that a
true ‘‘mixing’’ of arteriole and venule-specific characters is not
really occurring. Instead, the angiogenic neovessel phenotype may
reflect a more generic, ambiguous vessel phenotype, which gives
way to specific microvessel types as neovascularization progresses.
Moreover, growing evidence that vessel marker proteins have roles
other than establishing vessel identity in vessel sprouting during
vessel remodeling and angiogenesis, such as cell signaling modu-
lation and directing cell tip filopodial extension [22,29,30], rein-
forces this interpretation. Indeed, EphrinB2 can act as a pro-
angiogenic factor in postnatal neovascularization, since it is capable
of inducing neovascularization when delivered in a corneal micro-
pocket assay [31]. Regardless, our findings indicate that without
an additional assessment of vessel maturation, the use of EphrinB2
and EphB4 as vessel identity markers during active neovascular-
ization may be problematic.
Figure 5. Angiogenic neovessels exhibit reduced arterial and venous marker protein expression. A, Protein expression of EphrinB2 and
COUP-TFII in mature microvessels and angiogenic neovessels in tMVCs as described for Fig. 3E. B, EphrinB2 phosphorylation from similar preparations
as in A. * p,0.05, n=3 by Student’s t-test.
doi:10.1371/journal.pone.0027332.g005
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observed in the MVCs is in contrast with other reports describing
an increase in EphrinB2 mRNA in vascular cells and neovessels
associated with angiogenesis [14,31]. This difference likely reflects
the degree of pro-angiogenic activity in the different experimental
models. In the microvascular construct, angiogenic sprouting and
neovascularization occurs spontaneously in a fairly rarefied en-
vironment (collagen I gels and no added factors), as opposed
to cultured endothelial cells in Matrigel
TM (a complex, pro-
angiogenic matrix) treated with angiogenic factors[31] or ischemic
tissues in which cytokines and other growth factors are significantly
elevated as in these other studies [14,31]. Regardless, we show that
angiogenic neovessels, either in culture or implanted, do express
EphrinB2 and EphB4, albeit at reduced levels. If the presence of
EphrinB2 and EphB4 (as well as other identity markers) reflects
some level of specification, then it may be that the vascular system
in the implanted microvascular constructs is more plastic than
vascular systems in native tissues and that the tissue microenvi-
ronment contributes significantly to developing microvascular
network character. This is relevant for neovascularization-based
regenerative therapies, such as with the MVCs [15], where adap-
tation to the new tissue environment is important for the gener-
ation of a functional vascular bed.
VEGF-induced cell signaling has been implicated in AV spe-
cification during embryo development [32], suggesting that VEGF
could play a role in AV specification in adult neovascularization.
However, we have previously shown that VEGF is not responsible
for angiogenic sprouting in the MVCs [16,33], suggesting a dif-
ferent mechanism for the regulation of EphrinB2 and EphB4
expression and AV identity specification in our implant system. In
the MVCs, the re-appearance of distinct vessel types (defined by
morphologies and marker expression) coincides with the appear-
ance of blood flow and perivascular cell recruitment[16]. Elevated
shear stress induces arterial differentiation and mediates micro-
vascular remodeling [34,35,36] suggesting that it may be a key
stimulus. However, pulsatility and not shear stress amplitude may
be more important in initiating arterial-venous specification in
remodeling microvasculatures [37]. Certainly the pivotal role of
perivascular cells and Ephrin-mediated mural cell activity in vessel
maturation may also determine specific vessel phenotype [20,24].
Perivascular cells are essential for the formation of functional
blood vessels [38] by contributing to vessel stabilization and
maturation [39,40,41]. Indeed, the association of perivascular cells
to the neovessel may mark the end of vessel immaturity and
initiate structural adaptation[42]. Direct endothelial-perivascular
cell-cell interactions are regulated by Ephrin/Eph signaling [30]
and conditional deletion of the EphrinB2 gene in perivascular cells
results in fragile and dysfunctional microvessels [43]. Finally, Eph-
rinB2 expression in adult perivascular cells is restricted to the
arterial compartment of the vasculature [13,14] suggesting a possi-
ble role for perivascular cells in establishing an arterial phenotype.
Therefore, AV specification in adult neovascularization may be
driven by hemodynamic forces and perivascular cell activity,
associated with the specific needs of the tissue, rather than a pre-
determined program.
In our experiments, sprouting angiogenesis occurred from ar-
terioles. It is generally considered that angiogenesis arises pri-
marily from capillaries and post-capillary venules in vivo, par-
ticularly in tumors [44]. Whether or not angiogenesis occurs from
arterioles in native tissues, as suggested by our findings, is not
known since no systematic study has been performed. It is possible
that the isolation procedure whereby individual microvessels are
fragmented exposing cells of the microvessel wall to the matrix
environment stimulates angiogenesis and thus may be unique to
our system. However, similar such severing or breaking of micro-
vessels, of all types, may occur in situations of wounding and injury.
Regardless, our findings indicate that, as with capillaries and venules,
arterioles are capable of undergoing sprouting angiogenesis.
Methods
All animal experiments were performed in compliance with
institutional guidelines, conform with US National Institutes of
Health Guide for the Care and Use of Laboratory Animals and
were approved by University of Louisville Institutional Animal
Care and Use Committee procedures and policies (IACUC
#10105 and #10106 protocols).
Transgenic mouse and rat strains
Efnb2-reporter mouse. B6;129S4-Efnb2
tm2Sor/J mice
contain a histone H2B-GFP transgene inserted within the
arterial identity [14] Efnb2 gene [18].
Ephb4-reporter mouse. B6;129S7-Ephb4
tm1And/J mice
contain the Tau-LacZ transgene within the Ephb4 gene and
under control of the Ephb4 promoter[6] and used to locate
microvessels of venous identity[7]. In both cases, homozygous
mice die before birth. However, heterozygous animals develop
normally and were used as reporter for the specific gene activity.
Offspring from het x het breedings were genotyped using standard
PCR techniques according to Jackson Laboratories instructions.
EphrinB2-reporter primers: 59 -3 9 AAG TTC ATC TGG ACC
ACC G and TCC TTG AAG AAG ATG GTG CG. EphB4-
reporter primers: 59 -3 9 ATC GTT GAG AGG CCC TCG AC
(common), GTG CTA TTG GTC CGA AGT GTT (wild type)
and CTG AGC ATG ATC TTC CAT CAC (mutant)2.
GFP transgenic rat. SD-Tg(GFP)2BalRrrc rats contain an
EGFP transgene driven by the Ubc promoter integrated into a
single locus on chromosome 14 [45]. Except where indicated,
these rats served as the source of isolated microvessel segments.
Isolation of brain microvessel fragments of arterial
identity (aMF)
To isolate aMF, magnetic beads (11.3 mm mean diameter,
ranging from 10 to 13.9 mm; SPHERO
TM Carboxyl Magnetic
particles, CM-100-10, Spherotech, Lake Forest, IL) were delivered
to the brain vasculature via a PE 50 catheter introduced into the
left common carotid. Deep anesthesia was achieved by subcuta-
neous injection of a mixture of Ketamine (40 mg/Kg), Xylasine
(10 mg/Kg) and Acepromazine (2 mg/Kg). Intraoperative mon-
itoring of adequate anesthesia is done by toe pinchs. The animal
(mouse or rat) was placed supine and the fur over the lower jaw
down to the clavicle was removed with a depilator. Following a
midline incision, the left common carotid was exposed from the
internal/external branch point down to the proximal-most po-
sition in the neck. The proximal end was ligated, the distal end was
temporarily ligated, and the catheter introduced towards the brain
through a small incision in the common carotid wall. Bead
suspensions (75 mg/4 ml and 19 mg/1 ml in heparinized saline
for rat and mouse, respectively) were manually pushed through the
catheter using a syringe. Prior to use, beads were incubated
overnight with rocking in 1% BSA/PBS (Sigma). In the rat, the
vasculature was flushed with 2 ml of heparinized saline before
delivery of the beads. No such flush was done with the mouse
vasculature. Following the delivery of beads, the brain cortex was
harvested, minced, digested with collagenase (2 mg/ml, Worthing-
ton) and pelleted as previously described6. The digestate pellet was
suspended in 15% Dextran 100,000 to 200,000 MW (Sigma, St.
Louis, MO, USA) and centrifuged at 4000 xg at 4uC for 20 min.
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paration. Pelleted total segments were collected in divalent cation
free phosphate buffered saline with 0.1% bovine serum albumin
(BSA-PBS, Sigma, St. Louis, MO, USA) and selectively screened
by size [16]. After normal microvessel fragment isolation, the
fragments of arterial identity containing magnetic beads in their
lumens were separated from venules and capillaries by the use of
a magnet (Dynal
TM, Invitrogen, Carlsbad, CA, USA). Isolated
aMFs were repeatedly (5X) exposed to the magnet and washed to
improve recovery and enrichment.
Microvascular construct preparation and implantation
After isolation of microvessel segments from rodent brain cortex
or adipose tissue [16,46] isolated vessel segments were suspended
into liquid collagen type I at a density of 20,000 segments/ml. The
collagen was prepared by mixing sterile, acidified rat tail collagen
Type I (BD Biosciences, San Jose, CA, USA) with 1/4 volume of
ice cold 4x Dulbecco’s Modified Eagle’s Media (DMEM)
(Invitrogen, Carlsbad, CA, USA) and 1 M NaOH to yield a final
concentration of 3 mg/ml collagen. Segment/collagen suspen-
sions were pipetted into wells of a 48-well culture plate (0.2 ml/
well) and incubated at 37uC to polymerize the collagen to form a
three-dimensional microvascular construct (MVC). MVCs were
either cultured in DMEM+10%FBS or implanted subcutaneously
for 1 or 6 weeks on the flanks of immunodeficient mice (B6;129S7-
Rag1
tm1Mom/J) according to published methods [17,46]. Mice
were anesthetized with isoflurane (initially 4–5% in an induction
chamber then 2% via intubation tube) via precise vaporizer.
Monitoring of adequate anesthesia is done by toe pinchs. A sub-
cutaneous pocket was formed between the skin and the underlying
muscle anterior using blunt dissection through a small skin in-
cision. Each host mouse received 2 implants. The incision was
then closed with surgical staples and the animal was allowed to
recover. Unless indicated otherwise, microvessel isolates were
prepared from the GFP transgenic rats.
Implanted Microvascular Construct Visualization
MVCs were harvested at different time points following
implantation. For that, mice were anesthetized with isoflurane
(4–5% in an induction chamber) then euthanized by cervical
dislocation. MVCs were fixed in 4% paraformaldehyde for
2 hours and permeabilized with 0.5% Triton X-100 and rinsed
with PBS. After blocking for 2vhours with 10% goat serum (Sigma,
St. Louis, MO, USA), samples were incubated overnight with
different antibodies or lectins: Anti-EphB4 (R&D systems),
biotinylated Griffonia simplicifolia I (GSI; Vector labs, Burlin-
game, CA, USA), GSI-TRITC, streptavidin-Cy3 (Vector labs),
streptavidin-Cy5 (Vector labs), anti-a-smooth muscle actin (Sig-
ma), Zenon kit Alexa Fluor-594 (Invitrogen). Samples were
imaged en bloc with an Olympus MPE FV1000 Confocal Micro-
scope and resulting images analyzed with Amira 5.2 (Visage
Imaging, Inc, CA). Vessels were identified by either endogenous
expression of GFP or stained with GSI lectin. To identify
functional microvessels in the implanted constructs, host mice
were injected intravenously with a bolus of Dextran-TRITC
2,000,000 MW (Sigma, St. Louis, MO, USA) as a blood tracer
15 min before the constructs were harvested. As previously
described [16], implanted vessel fragments persist and form a
vessel network without significant contribution of host cells.
To detect LacZ activity, MVCs were harvested, fixed as
described above and cryoprotected in 30% sucrose in PBS at 4uC
for 3 days followed by mounting in freezing medium (Tissue-Tek
O.C.T. Compound, Sakura Finetek, Torrance, CA). MVCs were
sectioned in 20 mm slices utilizing a LEICA CM3050 cryostat
(Meyer Instruments, Inc, Houston, TX), thawed at room tem-
perature, washed 3 times in PBS, fixed with freshly prepared 0.5%
glutaraldehyde in PBS, washed 3 times for 15 min in wash buffer
(0.1 M PBS pH 7.3, 2 mM MgCl2, 0.02% NP-40) and incubated
with 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-b-galactopyra-
noside, Sigma, St. Louis, MO) in wash buffer containing 5 mM
potassium ferrocyanide and 5 mM potassium ferricyanide until
desired staining level was achieved.
Implanted MVC Analysis
After volume reconstruction from image stacks using Amira 5.2
(Visage Imaging, Inc, CA), vessel diameter and % vessel type was
measured for each microvessel element present in a field of view.
The fraction of the vascular volume comprised of arterial identity
was quantified by determining the ratio of the vascular volume
positive for GFP (i.e. EphrinB2-reporter) to the total vascular
volume (GSI-positive). Three fields of view per MVC were
counted per 3 different implanted MVCs.
Protein quantification by Western blotting
MVCs wereculturedin vitrofor7 days inDMEMcontaining10%
FBS to generate angiogenic neovessels. RIPA buffer (20 mM TRIS-
HCl pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1%
NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate,
1m Mb-glycerophosphate, 1 mM Na3VO4,1mg/ml leupeptin,
Cell Signaling, Danvers, MA) containing protease and phosphatase
inhibitors (Halt
TM protease and phosphatase inhibitor cocktails,
Thermo Scientific) was added to either fresh isolates (mature
specified vessels) or from angiogenic MVCs. Samples were ho-
mogenized onicewitha glasshomogenizertomacerate thecollagen
and incubated on ice for 30 min with mild agitation before
centrifugation at 14,000 rpm, 4uC for 10 min. Supernatant was
harvested and utilized for Western blotting following 4–15%
gradient SDS-PAGE (BioRad, Hercules, CA). EphrinB2 was
detected with a biotinylated anti-EphrinB2 antibody (Leinco, St.
Louis, MO) followed by streptavidin-HRP (DAKO). The bands
were detected with chemifluorescence substrate ECL plus (Amer-
sham, GE healthcare) with a Typhoon 9400 gel imager (GE
Healthcare, Piscataway, NJ) and were quantified by densitometry
using Metamorph
TM imaging software (Molecular Devices, Inc).
Analysis of EphrinB2 phosphorylation by Western
blotting
Lysates obtained as described abo v ew e r ea l s ou s e df o rE p h r i n B 2
immunoprecipitation. However, 1X volumes and 5X volumes of
lysates were used for immunoprecipitation from freshly isolated vessels
and angiogenic MVCs, respectively. Lysates were incubated with anti-
EphrinB2 antibody (Novus Bio, Littleton, CO) and protein A/G
agarose beads (Pierce, Rockford, IL) overnight at 4uC. Beads were
washed 5X with RIPA buffer containing protease and phosphatase
inhibitors, harvested and utilized for Western blotting following 4–
15% gradient SDS-PAGE (BioRad, Hercules, CA). EphrinB2 was
detected with a biotinylated anti-EphrinB2 antibody (Leinco, St.
Louis, MO) followed by strepavidin-HRP (DAKO). EphrinB2
tyrosine phosphorylation was detected with anti-P-Tyr (Millipore,
Billerica, MA). Bands were detected and quantified as above.
Statistical analysis
Data are expressed as mean 6 s.e.m. p-values were calculated
using Student’s t-test (SigmaStat v3, Systat software) for all
measurement comparisons except for vessel diameter distributions
which involved using Kruskal–Wallis One Way Analysis of
Variance on Ranks. p,0.05 was considered statistically significant.
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Sybr-green-based, real-time PCR was performed to determine
the relative expression of transcripts (rat Dll4, Efnb2, Nr2f2, Jag1,
Notch4 and Ephb4). To isolate total RNA, specified microvessels
(freshly isolated microvessel segments) or angiogenic MVCs (day 7
implants) were homogenized for 60 seconds in RNAzol-B (Tel-test
Inc., Friendswood, TX) and processed according to manufactur-
er’s instructions with the following modifications. 2X volumes of
RNAzol-B was used for MVCs. After homogenization, all samples
were incubated at RT for 10 min and centrifuged over phase-lock
gel (5Prime, Inc. Gaithersburg, MD) following the addition of
chloroform. Total RNA was alcohol precipitated in the presence
of 1 ml/ml of GlycoBlue (Ambion, Austin, TX). Three micro-
grams of total RNA was used to generate cDNA by reverse
transcription using the AffinityScrip QPCR cDNA Synthesis Kit
(Agilent Technologies, Santa Clara, CA). Primers were designed
using the Primer 3 web program (Table 1)9. For each sample,
average threshold values of triplicate runs for each gene per
sample were normalized to Dynactin1 values (DCt) to account for
template loading. We have previously shown that Dynaction1
expression is constitutive in the MVCs5. Analysis was performed
on 3 samples for each condition.
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